Literature DB >> 20128578

The impact of anti-inflammatory therapy on intraocular pressure reduction following selective laser trabeculoplasty.

Tony Realini1, Judie Charlton, Marc Hettlinger.   

Abstract

BACKGROUND AND
OBJECTIVE: To determine whether the use of postoperative topical anti-inflammatory therapy affects the intraocular pressure (IOP)-lowering efficacy of selective laser trabeculoplasty in eyes with primary open-angle glaucoma. PATIENTS AND METHODS: In this prospective, randomized, observer-masked study, 25 participants with primary open-angle glaucoma following bilateral 360 degrees selective laser trabeculoplasty used prednisolone acetate 1% four times daily in one randomly selected eye for 1 week. IOP was assessed at baseline and 1 week, 1 month, and 3 months after selective laser trabeculoplasty.
RESULTS: Baseline IOP and selective laser trabeculoplasty treatment parameters were comparable in both groups. Mean IOP was similar in eyes that did and did not receive steroid therapy at 1 week (17.0 vs 16.3 mm Hg, respectively, P = .613), 1 month (16.8 vs 16.2 mm Hg, respectively; P = .571), and 3 months (16.0 vs 15.8 mm Hg, respectively; P = .819).
CONCLUSION: A 1-week course of topical prednisolone acetate 1% four times daily did not affect the IOP-lowering effect of selective laser trabeculoplasty in eyes with primary open-angle glaucoma. Copyright 2010, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20128578     DOI: 10.3928/15428877-20091230-18

Source DB:  PubMed          Journal:  Ophthalmic Surg Lasers Imaging        ISSN: 1542-8877


  11 in total

1.  Selective laser trabeculoplasty induced changes in the thickness of ciliary body and iris evaluated by ultrasound biomicroscopy.

Authors:  Umit Aykan; Ilhami Salcan; Ozlem Yildirim; Dilaver Ersanli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-11-23       Impact factor: 3.117

Review 2.  Selective laser trabeculoplasty (SLT) vs other treatment modalities for glaucoma: systematic review.

Authors:  C McAlinden
Journal:  Eye (Lond)       Date:  2013-12-06       Impact factor: 3.775

3.  West Indies Glaucoma Laser Study (WIGLS) 3. Anterior Chamber Inflammation Following Selective Laser Trabeculoplasty in Afro-Caribbeans with Open-angle Glaucoma.

Authors:  Tony Realini; Hazel Shillingford-Ricketts; Darra Burt; Goundappa K Balasubramani
Journal:  J Glaucoma       Date:  2019-07       Impact factor: 2.503

4.  SALT Trial: Steroids after Laser Trabeculoplasty: Impact of Short-Term Anti-inflammatory Treatment on Selective Laser Trabeculoplasty Efficacy.

Authors:  Sylvia L Groth; Eiyass Albeiruti; Mariana Nunez; Roman Fajardo; Lucie Sharpsten; Nils Loewen; Joel S Schuman; Jeffrey L Goldberg
Journal:  Ophthalmology       Date:  2019-06-06       Impact factor: 12.079

Review 5.  Selective laser trabeculoplasty: past, present, and future.

Authors:  A Garg; G Gazzard
Journal:  Eye (Lond)       Date:  2018-01-05       Impact factor: 3.775

Review 6.  Laser trabeculoplasty for open-angle glaucoma and ocular hypertension.

Authors:  Christiane R Rolim-de-Moura; Augusto Paranhos; Mohamed Loutfi; David Burton; Richard Wormald; Jennifer R Evans
Journal:  Cochrane Database Syst Rev       Date:  2022-08-09

7.  West Indies Glaucoma Laser Study (WIGLS): 1. 12-Month Efficacy of Selective Laser Trabeculoplasty in Afro-Caribbeans With Glaucoma.

Authors:  Tony Realini; Hazel Shillingford-Ricketts; Darra Burt; Goundappa K Balasubramani
Journal:  Am J Ophthalmol       Date:  2017-09-28       Impact factor: 5.258

Review 8.  Perioperative medications for preventing temporarily increased intraocular pressure after laser trabeculoplasty.

Authors:  Linda Zhang; Jennifer S Weizer; David C Musch
Journal:  Cochrane Database Syst Rev       Date:  2017-02-23

9.  Low-energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial.

Authors:  Tony Realini; Gus Gazzard; Mark Latina; Michael Kass
Journal:  J Glaucoma       Date:  2021-07-01       Impact factor: 2.290

Review 10.  Selective laser trabeculoplasty: current perspectives.

Authors:  Kate E Leahy; Andrew Jr White
Journal:  Clin Ophthalmol       Date:  2015-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.